Analyst Ranking
Top 2%
#93 out of 5550 analysts
Average Return
+26.4%
Win Rate
56%130 out of 233
Risk vs Reward
Poor
Good

Mark Massaro's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Genedx Holdings CorpWGS
+776.23%$10.39$91.04
2024-04-22 -
2025-04-21
Strong Buy
Genedx Holdings CorpWGS
+585.24%$17.07$116.97
2024-04-30 -
2025-04-29
Strong Buy
Caredx IncCDNA
+489.41%$15.01$88.47
2025-11-06 -
2026-11-03
Strong Buy
Caredx IncCDNA
+370.09%$18.82$88.47
2026-02-26 -
2026-11-03
Strong Buy
Caredx IncCDNA
+325.34%$20.80$88.47
2026-04-29 -
2026-11-03
Strong Buy

Mark Massaro Analyst Color

Get additional color on Mark Massaro's coverage of popular stocks

Mark Massaro's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tempus Ai IncTEM
13Strong Buy$100.00+28.53%Maintains
2 days ago
Caredx IncCDNA
12Strong Buy$92.00+3.99%Maintains
6 days ago
Neogenomics IncNEO
6Strong Buy$28.00+66.37%Reiterates
7 days ago
Caris Life Sciences IncCAI
5Strong Buy$38.00+15.68%Maintains
8 days ago
Natera IncNTRA
16Strong Buy$430.00+10.65%Maintains
8 days ago
Guardant Health IncGH
13Strong Buy$210.00+20.00%Maintains
8 days ago
Lucid Diagnostics IncLUCD
8Strong Buy$2.50+511.25%Reiterates
13 days ago
Mdxhealth SaMDXH
12HoldN/AN/ADowngrades
17 days ago
Personalis IncPSNL
8HoldN/AN/ADowngrades
a month ago
Adaptive Biotechnologies CorpADPT
11Strong Buy$34.00+31.78%Maintains
a month ago
Ginkgo Bioworks Holdings IncDNA
8Strong Sell$5.00-53.53%Reiterates
2 months ago
Freenome IncFRNM
1Strong Buy$17.00+48.21%Initiates Coverage On
3 months ago
Alpha Teknova IncTKNO
2Strong Buy$8.00+8.99%Upgrades
3 months ago
Billiontoone IncBLLN
5Strong Buy$130.00+17.70%Maintains
3 months ago
Exagen IncXGN
9Strong Buy$9.00+7.91%Maintains
3 months ago
Sophia Genetics SaSOPH
7Strong Buy$9.00+30.25%Maintains
3 months ago
Genedx Holdings CorpWGS
12Strong Buy$90.00+31.12%Reiterates
3 months ago
Castle Biosciences IncCSTL
6Strong Buy$44.00+25.21%Maintains
3 months ago
Cerus CorpCERS
2Strong Buy$4.00+70.94%Upgrades
6 months ago
Idexx Laboratories IncIDXX
3Strong Buy$800.00+19.04%Maintains
9 months ago
Zoetis IncZTS
4Strong Buy$160.00+92.79%Reiterates
a year ago
Exact Sciences CorpEXAS
18HoldN/AN/ADowngrades
a year ago
Maxcyte IncMXCT
4HoldN/AN/ADowngrades
a year ago
Bionano Genomics IncBNGO
8HoldN/AN/ADowngrades
2 years ago
Akoya Biosciences IncAKYA
3HoldN/AN/ADowngrades
2 years ago
Dermtech IncDMTKQ
4Strong Buy$2.00N/AMaintains
3 years ago
Talis Biomedical CorpTLIS
3Strong Sell$5.00N/AMaintains
3 years ago
Cue Health IncHLTHQ
4Strong Buy$3.00N/AMaintains
3 years ago
Renalytix PLCRNLXY
3Strong Buy$3.50N/AMaintains
4 years ago
Lumiradx LtdLMDXF
1Strong Buy$4.00N/AMaintains
4 years ago
Phenomex IncCELL
2HoldN/AN/ADowngrades
4 years ago
T2 Biosystems IncTTOO
2HoldN/AN/ADowngrades
4 years ago
Quotient LtdQTNTQ
1Strong Buy$1.50N/AMaintains
4 years ago
Insight Molecular Diagnostics IncIMDX
1Strong Buy$100.00N/AInitiates Coverage On
6 years ago
Chembio Diagnostics IncCEMI
1Strong Buy$12.00N/AMaintains
7 years ago
Labcorp Holdings IncLH
4Hold$155.00N/AMaintains
8 years ago
Genmark Diagnostics IncGNMK
4Strong Buy$9.00N/AMaintains
8 years ago
Quest Diagnostics IncDGX
3Strong Buy$105.00N/AMaintains
8 years ago
Hologic IncHOLX
3Hold$41.00N/AMaintains
8 years ago
Quidelortho CorpQDEL
4Strong Buy$80.00N/AMaintains
8 years ago
Genomic Health IncGHDX
3Strong Buy$62.00N/AMaintains
8 years ago
Illumina IncILMN
3Strong Buy$340.00N/AMaintains
8 years ago
Heska CorpHSKA
2Strong Buy$123.00N/AMaintains
8 years ago
Htg Molecular Diagnostics IncHTGMQ
2Strong Buy$1,260.00N/AMaintains
9 years ago
Abaxis IncABAX
1Hold$47.00N/AMaintains
9 years ago
Alerislife IncALR
2HoldN/AN/ADowngrades
9 years ago
Alere IncALR1
4Hold$56.00N/ADowngrades
11 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.